Transplants in Myelodysplastic Syndromes

被引:1
作者
Wetzko, Katrin [1 ]
Platzbecker, Uwe [1 ]
机构
[1] TUD, Univ Hosp Carl Gustav Carus, Med Clin 1, D-01307 Dresden, Germany
关键词
MDS; Allogeneic HSCT; Relapse; Conditioning; Azacitidine; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; BONE-MARROW-TRANSPLANTATION; IDENTICAL SIBLING DONORS; VERSUS-HOST-DISEASE; SCORING SYSTEM; ALLOGENEIC TRANSPLANTATION; INDUCTION CHEMOTHERAPY; RISK MYELODYSPLASIA;
D O I
10.1016/j.hoc.2014.08.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myelodysplastic syndromes are one of the most common hematological disorders in the elderly. Therefore, an increase in the prevalence of de novo but also of secondary forms after prior chemotherapy or radiotherapy, respectively, is anticipated within the next years. Allogeneic stem cell transplantation is considered the only potentially curable therapy, but many patients are not eligible because of age or comorbidities. Reduced-intensity conditioning regimens have improved early tolerability of the procedure, although late effects remain a challenge in the care of these patients. However, hypomethylating agents have become available as alternative therapeutic approaches with a moderate toxicity profile.
引用
收藏
页码:1011 / +
页数:13
相关论文
共 50 条
[21]   A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial [J].
Gore, Steven D. ;
Fenaux, Pierre ;
Santini, Valeria ;
Bennett, John M. ;
Silverman, Lewis R. ;
Seymour, John F. ;
Hellstrom-Lindberg, Eva ;
Swern, Arlene S. ;
Beach, Charles. L. ;
List, Alan. F. .
HAEMATOLOGICA, 2013, 98 (07) :1067-1072
[22]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088
[23]   Revised International Prognostic Scoring System for Myelodysplastic Syndromes [J].
Greenberg, Peter L. ;
Tuechler, Heinz ;
Schanz, Julie ;
Sanz, Guillermo ;
Garcia-Manero, Guillermo ;
Sole, Francesc ;
Bennett, John M. ;
Bowen, David ;
Fenaux, Pierre ;
Dreyfus, Francois ;
Kantarjian, Hagop ;
Kuendgen, Andrea ;
Levis, Alessandro ;
Malcovati, Luca ;
Cazzola, Mario ;
Cermak, Jaroslav ;
Fonatsch, Christa ;
Le Beau, Michelle M. ;
Slovak, Marilyn L. ;
Krieger, Otto ;
Luebbert, Michael ;
Maciejewski, Jaroslaw ;
Magalhaes, Silvia M. M. ;
Miyazaki, Yasushi ;
Pfeilstoecker, Michael ;
Sekeres, Mikkael ;
Sperr, Wolfgang R. ;
Stauder, Reinhard ;
Tauro, Sudhir ;
Valent, Peter ;
Vallespi, Teresa ;
van de Loosdrecht, Arjan A. ;
Germing, Ulrich ;
Haase, Detlef .
BLOOD, 2012, 120 (12) :2454-2465
[24]   Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes [J].
Guardiola, P ;
Runde, V ;
Bacigalupo, A ;
Ruutu, T ;
Locatelli, F ;
Boogaerts, MA ;
Pagliuca, A ;
Cornelissen, JJ ;
Schouten, HC ;
Carreras, E ;
Finke, J ;
van Biezen, A ;
Brand, R ;
Niederwieser, D ;
Gluckman, E ;
de Witte, TM .
BLOOD, 2002, 99 (12) :4370-4378
[25]   Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine [J].
Itzykson, Raphael ;
Thepot, Sylvain ;
Quesnel, Bruno ;
Dreyfus, Francois ;
Beyne-Rauzy, Odile ;
Turlure, Pascal ;
Vey, Norbert ;
Recher, Christian ;
Dartigeas, Caroline ;
Legros, Laurence ;
Delaunay, Jacques ;
Salanoubat, Celia ;
Visanica, Sorin ;
Stamatoullas, Aspasia ;
Isnard, Francoise ;
Marfaing-Koka, Anne ;
de Botton, Stephane ;
Chelghoum, Youcef ;
Taksin, Anne-Laure ;
Plantier, Isabelle ;
Ame, Shanti ;
Boehrer, Simone ;
Gardin, Claude ;
Beach, C. L. ;
Ades, Lionel ;
Fenaux, Pierre .
BLOOD, 2011, 117 (02) :403-411
[26]   Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective casecontrol study [J].
Jabbour, Elias ;
Mathisen, Michael S. ;
Garcia-Manero, Guillermo ;
Champlin, Richard ;
Popat, Uday ;
Khouri, Issa ;
Giralt, Sergio ;
Kadia, Tapan ;
Chen, Julianne ;
Pierce, Sherry ;
Koca, Ebru ;
Daver, Naval ;
Tanaka, Maria ;
Rondon, Gabriela ;
Oran, Betul ;
Parmar, Simrit ;
Kantarjian, Hagop ;
de Lima, Marcos .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) :198-200
[27]   Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis [J].
Koreth, John ;
Pidala, Joseph ;
Perez, Waleska S. ;
Deeg, H. Joachim ;
Garcia-Manero, Guillermo ;
Malcovati, Luca ;
Cazzola, Mario ;
Park, Sophie ;
Itzykson, Raphael ;
Ades, Lionel ;
Fenaux, Pierre ;
Jadersten, Martin ;
Hellstrom-Lindberg, Eva ;
Gale, Robert Peter ;
Beach, C. L. ;
Lee, Stephanie J. ;
Horowitz, Mary M. ;
Greenberg, Peter L. ;
Tallman, Martin S. ;
DiPersio, John F. ;
Bunjes, Donald ;
Weisdorf, Daniel J. ;
Cutler, Corey .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) :2662-+
[28]   Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings [J].
Kroeger, N. ;
Zabelina, T. ;
de Wreede, L. ;
Berger, J. ;
Alchalby, H. ;
van Biezen, A. ;
Milpied, N. ;
Volin, L. ;
Mohty, M. ;
Leblond, V. ;
Blaise, D. ;
Finke, J. ;
Schaap, N. ;
Robin, M. ;
de Witte, T. .
LEUKEMIA, 2013, 27 (03) :604-609
[29]   Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia [J].
Lim, ZiYi ;
Brand, Ronald ;
Martino, Rodrigo ;
van Biezen, Anja ;
Finke, Juergen ;
Bacigalupo, Andrea ;
Beelen, Dietrich ;
Devergie, Agnes ;
Alessandrino, Emilio ;
Willemze, Roel ;
Ruutu, Tapani ;
Boogaerts, Marc ;
Falda, Michele ;
Jouet, Jean-Pierre ;
Niederwieser, Dietger ;
Kroger, Nicolaus ;
Mufti, Ghulam J. ;
De Witte, Theo M. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :405-411
[30]   Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients [J].
Luebbert, M. ;
Bertz, H. ;
Rueter, B. ;
Marks, R. ;
Claus, R. ;
Waesch, R. ;
Finke, J. .
BONE MARROW TRANSPLANTATION, 2009, 44 (09) :585-588